Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

Long since retired, but a public health educator to the end, I’d like to remind Florida residents, our political leadership, and Florida’s Surgeon General that prior to 1995, testing positive for HIV ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can ...

Understanding the benefits of early treatment for HIV is crucial for managing the disease effectively. Starting treatment soon after diagnosis not only preserves health but also enhances the quality ...

A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...

Nearly 20 states are moving to restrict assistance programs that help people afford HIV medications and treatment.

Merck said a treatment it is developing for HIV-1 met its primary endpoint in three Phase 3 trials. The biopharmaceutical company said Wednesday the results add to growing evidence for ...

Citing rising costs and shortfalls in federal support, about 20 states are toughening eligibility requirements for patients ...